Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)
NCT07067723 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 122
Last updated 2025-07-16
Summary
The goal of this observational study is
* to better understand the dominant modes of transmission
* to estimate the extent of transmission among contacts by determining the secondary infection rate for human-to-human transmission at an individual level and identifying factors associated with secondary infections.
* to determine the proportion of asymptomatic or pauci-symptomatic infections.
* to characterize the incubation period of mpox and the duration of infectiousness, including reproduction numbers.
* to assess serological responses following confirmed infection.
Conditions
- Monkeypox (Mpox)
Sponsors & Collaborators
-
Osaka Metropolitan University
lead OTHER
Principal Investigators
-
Yasutoshi Kido, Professor · Osaka Metropolitan University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
NCT07267390 ·Status: COMPLETED
-
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
NCT05651581 ·Status: COMPLETED ·Phase: NA
-
Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
NCT05784038 ·Status: RECRUITING
-
Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM
NCT05629299 ·Status: UNKNOWN ·Phase: NA
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox
NCT05476744 ·Status: COMPLETED
-
Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC
NCT05734508 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
NCT02859350 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating an Ebola and a Marburg Vaccine in Uganda
NCT00997607 ·Status: COMPLETED ·Phase: PHASE1
-
Break-through Infection Following Mpox vaccinatIon
NCT05522296 ·Status: COMPLETED
-
Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea
NCT03590340 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants
NCT02613520 ·Status: COMPLETED ·Phase: PHASE1
-
French West Indies Leptospirosis Study
NCT01607047 ·Status: UNKNOWN
-
COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response
NCT05228639 ·Status: COMPLETED
-
101-PGC-005 for the Treatment of COVID-19
NCT05656521 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Controlled Human Plasmodium Vivax Infection
NCT03377296 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey
NCT04470648 ·Status: COMPLETED
-
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
NCT03631719 ·Status: COMPLETED
-
Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali
NCT04710316 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)
NCT06958198 ·Status: RECRUITING ·Phase: PHASE1
-
Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences
NCT04932837 ·Status: WITHDRAWN
-
Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults
NCT02418962 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
NCT03503058 ·Status: COMPLETED ·Phase: PHASE2
-
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
NCT02530697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
NCT00513669 ·Status: COMPLETED ·Phase: PHASE1